Amarantus Bioscience Holdings Inc (AMBS)

[Chelby84]

NEWS OUT!!!!:

"My Account" tab.
News for 'AMBS' - (Amarantus BioScience President & CEO, Gerald Commissiong Publishes New Blog Post Titled ''The Stage is Now Set for Growth: Focus on Parkinson's and Alzheimer's'')


Mar 25, 2013 (ACCESSWIRE-TNW via COMTEX) -- Amarantus BioScience, Inc. (OTCQB:
AMBS), a biotechnology company discovering and developing treatments and
diagnostics for diseases associated with neurodegeneration and apoptosis
centered around its patented therapeutic protein Mesencephalic Astrocyte
Neurotrophic Factor (MANF), today published a blog post entitled "The Stage is
Now Set for Growth: Focus on Parkinson's and Alzheimer's" on
TheChairmansBlog.com. TheChairmansBlog.com is an exclusive online media
publication that enables key executive officers a unique platform to share
insights about their company and industry trends.

Amarantus' President & CEO, Gerald Commissiong, provides insight into what the
Company has been focusing their efforts on in the first quarter. Mr. Commissiong
writes that the Management Team has "invested significant time preparing the
foundation for the proper evolution of the Company." He updates shareholders on
upcoming Company announcements and what to expect in the second quarter. Read
the full blog post from Gerald Commissiong on TheChairmansBlog.com
(http://www.thechairmansblog.com/gerlad-commissiong/2013-03/the-stage-is-now-set-for-growth-focus-on-parkinsons-and-alzheimers.html)

Amarantus BioScience, Inc. is a development-stage biotechnology company founded
in January 2008. The Company is focused on developing unique products and
proprietary technologies for the potential treatment and/or diagnosis of
Parkinson's disease, Traumatic Brain Injury, Ischemic Heart Disease and other
human diseases. The Company owns the intellectual property rights to
Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing
MANF-based products as treatments for neurological disorders where there is a
significant unmet medical need. The Company also is a Founding Member of the
Coalition for Concussion Treatment (#C4CT), a movement initiated in
collaboration with Brewer Sports International seeking to raise awareness of new
treatments in development for concussions and related nervous-system disorders.
For further information please visit www.Amarantus.com.

TheChairmansBlog.com is an exclusive, online media publication where publicly
and privately held firms alike share insights about their companies and
industries. TheChairmansBlog.com enables upper tier management to discuss issues
that are of importance to their stakeholders, shareholders, and interested
parties in an informal environment. In addition to management's insightful blog
posts, TheChairmansBlog.com staff and aggregate partners contribute articles on
finance, technology, health and energy while providing updated market trends
news and information.




Copyright 2013 ACCESSWIRE-TNW

-0-